MetLife Investment Management’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
27,320
+2,212
+9% +$79.5K 0.01% 1447
2026
Q1
$806K Buy
25,108
+463
+2% +$17K ﹤0.01% 1503
2025
Q4
$946K Sell
24,645
-1,545
-6% -$33.9K ﹤0.01% 1462
2025
Q3
$360K Hold
26,190
– – ﹤0.01% 1978
2025
Q2
$338K Buy
26,190
+2,155
+9% +$22.4K ﹤0.01% 1882
2025
Q1
$270K Sell
24,035
-504
-2% -$6.62K ﹤0.01% 2035
2024
Q4
$322K Buy
24,539
+1,527
+7% +$39.2K ﹤0.01% 2032
2024
Q3
$920K Buy
23,012
+16,641
+261% +$605K 0.01% 1434
2024
Q2
$188K Buy
+6,371
New +$173K ﹤0.01% 2288

Other funds holding PACS

MetLife Investment Management's PACS Position: Q2 2026 in Review

MetLife Investment Management increased its PACS Group (PACS) stake by 8.8% in Q2 2026, buying an estimated $79.5K and bringing the position to 27,320 shares worth $1.16M. The position accounts for 0.01% of the portfolio, ranked #1447.

MetLife Investment Management first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • MetLife Investment Management held 27,320 shares of PACS Group worth $1.16M as of Q2 2026.
  • MetLife Investment Management bought 2,212 PACS Group shares in Q2 2026, an estimated $79.5K.
  • PACS Group made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1447 holding.
  • MetLife Investment Management first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.